gene

TMEM106B

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TMEM106B: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

383Connections
0Hypotheses
0Analyses
50Outgoing
50Incoming
1Experiments
0Debates

Summary

TMEM106B is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, interacts with. Associated with Aging, Als, Alzheimer. Connected to 27 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolTMEM106B
AliasesTransmembrane Protein 106B
Chromosome7p21.3
Protein FamilyType II lysosomal transmembrane protein family
Functionis a 323-amino acid type II lysosomal transmembrane protein encoded by the TMEM106B gene on chromosome 7p21.
Primary ExpressionLate endosomes and lysosomes
Molecular Weight30.3 kDa
Amino Acids274 aa
Exons9
PathwaysAutophagy, endosome-lysosome function
UniProt IDQ9NUM4
GeneCardsTMEM106B
Human Protein AtlasTMEM106B
Molecular weightApproximately 31 kDa
TopologyType II transmembrane protein (N-out, C-in)
Associated DiseasesAging, Als, Alzheimer, Alzheimer's disease
InteractionsActin, ALZHEIMER, ALZHEIMER DISEASE, AMYLOID, AND, APOE
KG Connections383 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING
🔮 Predicted Structure: TMEM106B — AlphaFold Q9NUM4 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (6)

Knowledge base pages for this entity

Canonical Page

TMEM106B

protein · 1600 words

TMEM106B — Transmembrane Protein 106B

gene · 1257 words

TMEM106B Protein (Transmembrane Protein 106B)

protein · 1173 words

TMEM106B Genetic Modifiers in FTD

disease · 935 words

TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeutic Exploitation

experiment · 641 words

TMEM106B Lysosomal Restoration Therapy for Neurodegeneration

general · 608 words

Pathway Diagram

graph TD
    TMEM106B["TMEM106B"]
    endosome_lysosome_function(["endosome-lysosome function"])
    TMEM106B -->|"regulates"| endosome_lysosome_function
    Alzheimer{"Alzheimer"}
    TMEM106B -->|"associated with"| Alzheimer
    TMEM106B -->|"therapeutic target"| Alzheimer
    Ms{"Ms"}
    TMEM106B -->|"therapeutic target"| Ms
    Dementia{"Dementia"}
    TMEM106B -->|"therapeutic target"| Dementia
    Als{"Als"}
    TMEM106B -->|"therapeutic target"| Als
    TMEM106B -->|"associated with"| Als
    Aging{"Aging"}
    TMEM106B -->|"associated with"| Aging
    TMEM106B -->|"interacts with"| Dementia
    SIGLEC9["SIGLEC9"]
    TMEM106B -->|"associated with"| SIGLEC9
    SIRPA["SIRPA"]
    TMEM106B -->|"associated with"| SIRPA
    GRN["GRN"]
    TMEM106B -->|"associated with"| GRN
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
    ALZHEIMER_S_DISEASE -->|"associated with"| TMEM106B
    TREM2["TREM2"]
    TREM2 -->|"associated with"| TMEM106B
    ALZHEIMER_S_DISEASE -->|"therapeutic target"| TMEM106B
    CTSH["CTSH"]
    CTSH -->|"associated with"| TMEM106B
    FTLD["FTLD"]
    FTLD -->|"associated with"| TMEM106B
    MAPT["MAPT"]
    MAPT -->|"associated with"| TMEM106B
    style TMEM106B fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (209)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:TMEM106Bdata_indataset_row0.00
ds-83b31ef18d49provides_data_fordataset1.00
Cell Subtype Proportionregulatesphenotype0.90
oxidative stress responseparticipates_inpathway0.80
endosome-lysosome functionregulatespathway0.70

Incoming (174)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:TMEM106Bdata_indataset_row0.00
ds-83b31ef18d49data_indataset1.00
ALZHEIMER DISEASEassociated_withgene0.80
DEMENTIAinhibitsdisease0.65
C9orf72interacts_withgene0.65

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeu validation Neurodegeneration 0.400 0.50 human proposed $2,730,000

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning TMEM106B in their description or question text

No additional research found